BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23291148)

  • 41. Hypertension: An Important But Reversible Cause of Systolic Dysfunction in a Cohort of Pediatric Patients.
    Kamsheh AM; Meyers KE; Palermo RA; Wu L; Burstein DS; Edelson JB; Lin KY; Maeda K; Rossano JW; Wittlieb-Weber CA; O'Connor MJ
    Pediatr Cardiol; 2024 Feb; 45(2):331-339. PubMed ID: 37884820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Pulmonary Hypertension in Chronic Kidney Disease Patients using Doppler Echocardiography.
    Gaur J; Singh RK; Kulkarni C; Dube S
    Heart Views; 2023; 24(1):24-28. PubMed ID: 37124428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study.
    Farzaneh-Far R; Desir GV; Na B; Schiller NB; Whooley MA
    PLoS One; 2010 Oct; 5(10):e13496. PubMed ID: 20975995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T Cells Play a Causal Role in Diastolic Dysfunction during Uremic Cardiomyopathy.
    Winterberg PD; Robertson JM; Kelleman MS; George RP; Ford ML
    J Am Soc Nephrol; 2019 Mar; 30(3):407-420. PubMed ID: 30728178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of cardiac remodeling associated with renal function in mediating cardiovascular event outcomes.
    Lv Z; Fu Y; Liu C; Ma Y; Yuan M; Ren J; Gao D
    iScience; 2024 Mar; 27(3):109143. PubMed ID: 38384844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD.
    Deo R; Shou H; Soliman EZ; Yang W; Arkin JM; Zhang X; Townsend RR; Go AS; Shlipak MG; Feldman HI
    J Am Soc Nephrol; 2016 Feb; 27(2):559-69. PubMed ID: 26160896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study.
    Chirinos JA; Khan A; Bansal N; Dries DL; Feldman HI; Ford V; Anderson AH; Kallem R; Lash JP; Ojo A; Schreiber M; Sheridan A; Strelsin J; Teal V; Roy J; Pan Q; Go AS; Townsend RR; ;
    Circ Heart Fail; 2014 Sep; 7(5):709-16. PubMed ID: 25059422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study.
    Lin YC; Bansal N; Vittinghoff E; Go AS; Hsu CY
    BMC Nephrol; 2013 Dec; 14():268. PubMed ID: 24305166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
    Scialla JJ; Lau WL; Reilly MP; Isakova T; Yang HY; Crouthamel MH; Chavkin NW; Rahman M; Wahl P; Amaral AP; Hamano T; Master SR; Nessel L; Chai B; Xie D; Kallem RR; Chen J; Lash JP; Kusek JW; Budoff MJ; Giachelli CM; Wolf M;
    Kidney Int; 2013 Jun; 83(6):1159-68. PubMed ID: 23389416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac troponins in patients with chronic kidney disease and kidney transplant recipients without acute cardiac symptoms.
    Ahmadi F; Dolatkhani F; Lessan-Pezeshki M; Mahdavi-Mazdeh M; Abbasi MR; Mohebi-Nejad A
    Iran J Kidney Dis; 2014 Jan; 8(1):31-6. PubMed ID: 24413718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).
    Dubin RF; Li Y; He J; Jaar BG; Kallem R; Lash JP; Makos G; Rosas SE; Soliman EZ; Townsend RR; Yang W; Go AS; Keane M; Defilippi C; Mishra R; Wolf M; Shlipak MG;
    BMC Nephrol; 2013 Oct; 14():229. PubMed ID: 24148285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of troponin T as a screening test of cardiac structure and function in chronic kidney disease.
    Nasr FM; Metwaly A; Khalik AA; Raafat M; Nabil M; Kamel L; Elsheikh N
    Glob Cardiol Sci Pract; 2021 Dec; 2021(4):e202126. PubMed ID: 36185160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.
    Lidgard B; Zelnickv L; Anderson AH; Feldman H; Go A; He J; Kansal M; Mohanty MJ; Mehta R; Shlipak MG; Soliman E; Weir MR; Bansal N;
    Kidney360; 2022 May; 3(5):859-871. PubMed ID: 36128494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction.
    Lidgard B; Zelnick LR; Go A; O'Brien KD; Bansal N;
    J Am Heart Assoc; 2022 Jun; 11(11):e024913. PubMed ID: 35621223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of three major co-morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction.
    Benes J; Kotrc M; Jarolim P; Hoskova L; Hegarova M; Dorazilova Z; Podzimkova M; Binova J; Lukasova M; Malek I; Franekova J; Jabor A; Kautzner J; Melenovsky V
    ESC Heart Fail; 2021 Apr; 8(2):1417-1426. PubMed ID: 33512782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
    Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study).
    Wang K; Zelnick LR; Anderson A; Cohen J; Dobre M; Deo R; Feldman H; Go A; Hsu J; Jaar B; Kansal M; Shlipak M; Soliman E; Rao P; Weir M; Bansal N;
    Kidney Int Rep; 2020 Nov; 5(11):2002-2012. PubMed ID: 33163721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical importance of high- sensitivity troponin T in patients without coronary artery disease.
    Askin L; Tanriverdi O; Turkmen S
    North Clin Istanb; 2020; 7(3):305-310. PubMed ID: 32478307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.